{
    "Variants Include": [
        {
            "Gene": "a - synuclein (aS)",
            "variants": [
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "GCT",
                        "alt": "CCT",
                        "position": "90 - 92"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's disease",
        "MONDO": "MONDO:0005294"
    },
    "Experiment Method": [
        {
            "Assay Method": "Quenched hydrogen/deuterium exchange coupled to NMR spectroscopy",
            "Material used": {
                "Material Source": "Recombinant protein from E. Coli",
                "Material Name": "15N isotope labeled recombinant wt and A30P aS",
                "Description": "15N isotope labeled recombinant wt and A30P aS were expressed and purified from E. Coli. Protein solutions were prepared in 20 mM Tris - HCl (pH 7.5 at 25 C), 100 mM NaCl and 0.02% NaN3 with protein concentrations of $100 \mu M$. Fibrillization was achieved by incubation at 37 C for 7 days with agitation."
            },
            "Readout type": "Quantitative (peak intensity ratios in NMR spectra)",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "The A30P mutation does not cause changes in the number, location and overall arrangement of b - strands in amyloid fibrils of aS",
                    "Molecular Effect": "No significant change in the structure of amyloid fibrils",
                    "Result Description": "Back - exchange profiles and deuterium incorporation levels showed highly similar solvent protection profiles for A30P and wt aS. Minor differences were attributed to small conformational differences, variations in aggregation, and the polymorphic nature of amyloid fibrils."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Two - dimensional proton - detected high - resolution magic angle spinning (HR - MAS) experiments",
            "Material used": {
                "Material Source": "Recombinant protein from E. Coli",
                "Material Name": "15N isotope labeled recombinant wt and A30P aS",
                "Description": "15N isotope labeled recombinant wt and A30P aS were expressed and purified from E. Coli. Protein solutions were prepared in 20 mM Tris - HCl (pH 7.5 at 25 C), 100 mM NaCl and 0.02% NaN3 with protein concentrations of $100 \mu M$. Fibrillization was achieved by incubation at 37 C for 7 days with agitation. Fibrils were resuspended in 50 mM HEPES (pH 7.4), 100 mM NaCl solution for HR - MAS NMR measurements."
            },
            "Readout type": "Qualitative (presence and dispersion of peaks in NMR spectra)",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "Several residues within the fibrillar core retain nano - second dynamics",
                    "Molecular Effect": "Indicates flexibility in the fibrillar core",
                    "Result Description": "The 2D 1H, 15N - HSQC spectrum showed a narrow dispersion of peaks. Signals of 28 residues in the region 98 - 140 could be identified, and some signals overlapping with monomeric aS residues were tentatively assigned to the core of aS fibrils, suggesting the presence of dynamics in the fibrillar core."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Electron microscopy",
            "Material used": {
                "Material Source": "Recombinant protein from E. Coli",
                "Material Name": "aS fibrils",
                "Description": "aS fibrils were prepared on a glow - discharged carbon foil and stained with 1% uranyl acetate."
            },
            "Readout type": "Qualitative (morphology of amyloid fibrils)",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "The morphology of amyloid fibrils was characteristic for amyloid fibrils",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Electron microscopy showed a morphology characteristic for amyloid fibrils."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Thioflavin T fluorescence assay",
            "Material used": {
                "Material Source": "Recombinant protein from E. Coli",
                "Material Name": "aS fibrils and monomeric aS",
                "Description": "aS fibrils and monomeric aS were used to monitor fibrillization."
            },
            "Readout type": "Quantitative (fluorescence intensity)",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "Fibrillization was achieved",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Fibrillization was monitored by a thioflavin T fluorescence assay."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}